V

Vaximm AG

4 employees

VAXIMM is a vaccine company offers VXM01 targeting tumor vasculature.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Developer Platform
Therapeutics
immunotherapies and glioblastoma

Date founded

2008

Funding rounds raised

Total raised

$8M

from 2 investors over 2 rounds

V

Vaximm AG raised $8M on January 12, 2011

Investors: BioMedPartners and Sunstone Life Science Ventures

FAQ